AHA today submitted a statement to the House Energy and Commerce Subcommittee on Health for a hearing this afternoon examining price transparency and competition in health care. The statement highlights hospitals’ high compliance with the Hospital Price Transparency Rule and recommends actions to streamline transparency policies. It also explains how some hospitals use mergers and acquisitions to expand access to services and better serve patients where they live. In addition, AHA strongly opposes expanding Medicare site-neutral payment policies, which threaten access to care in rural and historically marginalized communities; further restricting access to the 340B Drug Pricing Program, which allows hospitals to reduce the price of outpatient pharmaceuticals and expand health services for low-income patients and communities; or repealing a 2010 law limiting physician referrals to new hospitals in which they have an ownership interest.

Related News Articles

Headline
The House Energy and Commerce Subcommittee on Health May 17 considered a series of health care bills, including a number focused on provisions that would…
Headline
In a statement submitted to the House Ways and Means Committee for a hearing May 16 on health care price transparency, AHA recommended Congress and the…
Headline
The Centers for Medicare & Medicaid Services today announced changes (https://www.cms.gov/newsroom/fact-sheets/hospital-price-transparency-enforcement-…
Headline
The AHA strongly opposes legislation that would lead to additional site-neutral payment cuts and threaten access to patient care, Ashley Thompson, AHA senior…
Headline
About 84% of hospitals had posted a machine-readable file containing rate information by the end of first-quarter 2023, up from 65% the previous quarter,…
Blog
The AHA has previously noted the third party observers who demonstrate a tenuous grasp of the data and rules regarding federal hospital transparency…